Even though PSA is used as a tool for PCa screening, prognosis, and monitoring therapeutic response, elevations in PSA levels have also been obtained in cases such as inflammation and non-malignant benign prostate hyperplasia. This evidence concerns the gene KLK3 and posterior cortical atrophy.